Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen


Clinical Trial Description

Subjects will be randomized to receive perioperative dosing of either:

1. Oral acetaminophen (Tylenol) 1000mg with IV Placebo (100ml Normal Saline), OR,

2. IV acetaminophen (Ofirmev) 1000mg/100ml with Oral Placebo (oral capsules).

Subject pain levels and post-operative opioid use will be tracked for up to 24 hours after surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02244619
Study type Interventional
Source Kettering Health Network
Contact
Status Completed
Phase Phase 4
Start date September 2014
Completion date April 2016

See also
  Status Clinical Trial Phase
Withdrawn NCT01939379 - Adductor Canal Nerve Block Following Total Knee Arthroplasty N/A
Not yet recruiting NCT02123979 - Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model Phase 2